|« Previous month||Next month »|
23-Dec-2011 - In-Pharmatechnologist.com would like to wish all our readers a happy holiday
22-Dec-2011 - The US FDA is seeking information to help it protect celiac disease patients from pharma ingredients derived from wheat, barley, or rye.
22-Dec-2011 - Pall will buy US instrument maker ForteBio next year in a continuation of efforts to build its biomanufacturing technology offering.
22-Dec-2011 - Amgen has partnered with non-branded drugmaker Watson to develop biosimilar cancer drugs in a deal that goes some way towards protecting its own portfolio from generic competition.
22-Dec-2011 - Electroporation is the wave of the future for transdermal drug delivery, according to Parexel’s Ravi Harapanhalli.
21-Dec-2011 - It’s been a busy year for API (active pharmaceutical ingredient) manufacturers with new facilities, cost pressures and regulatory developments all hitting the headlines.And it seems recent developments in HPAPIs (high...
21-Dec-2011 - Ranbaxy has signed a consent decree with the US FDA and set aside $500m for penalty payments to settle its longstanding dispute.
21-Dec-2011 - Eli Lilly is collaborating with Arecor to develop stable aqueous or higher concentration formulations of protein and peptide drugs.
21-Dec-2011 - Intracellular drug delivery testing could become quicker thanks to probes that "light up" when a medicine is delivered to a tumour.
20-Dec-2011 - DSM Biologics will work with the Australian Institute for Bioengineering and Nanotechnology (AIBN) on the commercialisation of development-stage biologics projects.
20-Dec-2011 - China will keep its position as a leading API and intermediates supplier thanks to recovering global demand and the growth of the generic sector say market analysts.
20-Dec-2011 - Eli Lilly has expanded its drug delivery partnership with Starpharma to include further in vivo studies and clinical testing.
20-Dec-2011 - Counterfeit anti-malarials containing the Viagra API were probably manufactured in Southeast Asia, researchers found.
19-Dec-2011 - BASF has raised its prices for three ethanolamines (EOA), key intermediates in the production of a wide range of active pharmaceutical ingredients (API).
19-Dec-2011 - Drug-loaded lollipops are the ideal dosage form to boost compliance in children with oral thrush, Indian researchers found.
19-Dec-2011 - in-PharmaTechnologist presents its weekly round-up of the latest appointments within the pharmaceutical industry, including news from Vertex, Pfizer and Prolong.
19-Dec-2011 - Manufacturers of certain critical drugs must report production interruptions to the FDA under a new interim final rule.
19-Dec-2011 - GE Healthcare wont say if its new turnkey biologics plant development service will offer Governments in emerging nations discounted rates.
15-Dec-2011 - Seppic has seen a boom in demand for its new natural origin coating agents for pharmaceuticals, which can speed up production time by 50 per cent at lab stage.
15-Dec-2011 - Researchers have developed a Trojan-horse-style delivery system that transports steroids to the retina for the treatment of age-related macular degeneration and retinitis pigmentosa.
15-Dec-2011 - A treaty on medicine quality is needed to fix the major public health problem of substandard drugs, according to academics.
15-Dec-2011 - AMPAC posted a fourth quarter loss as process improvement difficulties offset rising demand for CNS and oncology ingredients.
14-Dec-2011 - UK-headquartered Archimedes Pharma has licensed its Targit drug delivery tech to Sweden’s Pharmalink AB for its candidate renal failure treatment, Nefecon.
14-Dec-2011 - GE Healthcare and M+W Group aim to capture a share of the rapidly expanding global biologics market with a new plant and manufacturing tech partnership.
14-Dec-2011 - The EMA has recommended recalling a batch of Gilead’s Vistide manufactured by Ben Venue over particle contamination concerns.
|« Previous month||Next month »|